Neoadjuvant Recombinant Vaccinia Virus for Metastatic Colorectal Cancer With Liver Resection

Summary

This is a neoadjuvant Phase 2a, open-label trial in patients with metastatic colorectal carcinoma who are undergoing a complete resection of the metastatic colorectal tumors in their liver.

Timeline

Start

2011-10

Primary completion

2012-01

Completion

2013-03

Outcome

Outcome not reported

Stopped (Business): “Business decision by the sponsor”

Drugs

Indications